Literature DB >> 12629555

Endogenous cannabinoid system as a modulator of food intake.

D Cota1, G Marsicano, B Lutz, V Vicennati, G K Stalla, R Pasquali, U Pagotto.   

Abstract

The ability of Cannabis sativa (marijuana) to increase hunger has been noticed for centuries, although intensive research on its molecular mode of action started only after the characterization of its main psychoactive component Delta(9)-tetrahydrocannabinol in the late 1960s. Despite the public concern related to the abuse of marijuana and its derivatives, scientific studies have pointed to the therapeutic potentials of cannabinoid compounds and have highlighted their ability to stimulate appetite, especially for sweet and palatable food. Later, the discovery of specific receptors and their endogenous ligands (endocannabinoids) suggested the existence of an endogenous cannabinoid system, providing a physiological basis for biological effects induced by marijuana and other cannabinoids. Epidemiological reports describing the appetite-stimulating properties of cannabinoids and the recent insights into the molecular mechanisms underlying cannabinoid action have proposed a central role of the cannabinoid system in obesity. The aim of this review is to provide an extensive overview on the role of this neuromodulatory system in feeding behavior by summarizing the most relevant data obtained from human and animal studies and by elucidating the interactions of the cannabinoid system with the most important neuronal networks and metabolic pathways involved in the control of food intake. Finally, a critical evaluation of future potential therapeutical applications of cannabinoid antagonists in the therapy of obesity and eating disorders will be discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12629555     DOI: 10.1038/sj.ijo.0802250

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  72 in total

1.  Role of neuronal nitric oxide synthase in the estrogenic attenuation of cannabinoid-induced changes in energy homeostasis.

Authors:  Amanda Borgquist; Cecilia Meza; Edward J Wagner
Journal:  J Neurophysiol       Date:  2014-11-12       Impact factor: 2.714

Review 2.  Antagonizing the cannabinoid receptor type 1: a dual way to fight obesity.

Authors:  D Cota; S Genghini; R Pasquali; U Pagotto
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

3.  The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin.

Authors:  Sonia A Tucci; Elizabeth K Rogers; Marta Korbonits; Tim C Kirkham
Journal:  Br J Pharmacol       Date:  2004-09-20       Impact factor: 8.739

Review 4.  Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system?

Authors:  Rebecca M Craft; Julie A Marusich; Jenny L Wiley
Journal:  Life Sci       Date:  2012-06-20       Impact factor: 5.037

5.  The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice.

Authors:  Garron T Dodd; Giacomo Mancini; Beat Lutz; Simon M Luckman
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

6.  Cannabinoid facilitation of behavioral and biochemical hedonic taste responses.

Authors:  M A De Luca; M Solinas; Z Bimpisidis; S R Goldberg; G Di Chiara
Journal:  Neuropharmacology       Date:  2011-11-02       Impact factor: 5.250

Review 7.  [The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders].

Authors:  U Schneider; J Seifert; M Karst; J Schlimme; K Cimander; K R Müller-Vahl
Journal:  Nervenarzt       Date:  2005-09       Impact factor: 1.214

8.  Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes.

Authors:  Régis Roche; Laurence Hoareau; Sandrine Bes-Houtmann; Marie-Paule Gonthier; Christine Laborde; Jean-François Baron; Yacine Haffaf; Maya Cesari; Franck Festy
Journal:  Histochem Cell Biol       Date:  2006-01-04       Impact factor: 4.304

9.  Reduced sensitivity to reward in CB1 knockout mice.

Authors:  Carles Sanchis-Segura; Brandon H Cline; Giovanni Marsicano; Beat Lutz; Rainer Spanagel
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

10.  Synthesis of phenoxyacyl-ethanolamides and their effects on fatty acid amide hydrolase activity.

Authors:  Lionel Faure; Subbiah Nagarajan; Hyeondo Hwang; Christa L Montgomery; Bibi Rafeiza Khan; George John; Peter Koulen; Elison B Blancaflor; Kent D Chapman
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.